December 27th, 2007
A new experimental drug has been found by Oregon Health & Science University (OHSU) Cancer Institute researchers to be effective against a highly resistant mutation in chronic myeloid leukemia (CML).
The said new drug candidate - SGX393 - has been found to inhibit most resistant mutations — including T315I — both in mouse models and […]
By Gloria Gamat -- 0 comments
November 23rd, 2007
Multiple myeloma is a cancer that occurs in the blood-making cells of bone marrow.
Abramson Cancer Center of the University of Pennsylvania recently announced the fndings from two large, international clinical trials: with the oral drug lenalidomide (REVLIMID®), in combination with the steroid dexamethasone, patients significantly improved by all measures where previous treatments had failed.
A product […]
By Gloria Gamat -- 0 comments
November 12th, 2007
According to a new study from St. Jude Children’s Research Hospital, the anti-leukemia drug dexamethasone contributes to a relentless fatigue and poor quality of sleep in children undergoing treatment for acute lymphoblastic leukemia (ALL) – thereby suggesting that clinicians could improve the quality of life for these children by developing new methods of drug administration […]
By Gloria Gamat -- 0 comments
October 8th, 2007
The drug imatinib has been found to drive cancer into remission in people with chronic myeloid leukemia (CML). But CML often returns when treatment is stopped.
Now, according to a new research by a team from UC-Irvine, imatinib could cure CML under certain circumstances if it is taken over a long enough period of time.
According to […]
By Gloria Gamat -- 0 comments
July 26th, 2007
The most common leukaemia in the developed world, chronic lymphocytic leukaemia (CLL) remains incurable while the best treatment continues to be defined by research.
Compared with single treatment with either agent alone, the combination treatment of fludarabine plus cyclophosphamide for chronic lymphocytic leukaemia (CLL) greatly increases progression-free survival and response rates.
Such were the findings of Professor […]
By Gloria Gamat -- 0 comments
June 26th, 2007
Barr Pharmaceuticals, Inc.’s generic version of Roche Laboratories Inc.’s VESANOID® (tretinoin) Capsules, 10 mg has been approved by the FDA.
VESANOID® (tretinoin) capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL).
Acute promyelocytic leukemia (APL) is a subtype of the cancer acute myeloid leukemia (AML).
APL is characterized by abnormal, heavily granulated […]
By Gloria Gamat -- 0 comments
May 18th, 2007
The Leukemia & Lymphoma Society’s Co-Pay Assistance Program is a program designed to provide financial assistance for people struggling with costly drug co-pays:
As you may know, a diagnosis of leukemia, Hodgkin or non-Hodgkin lymphoma, myeloma or other blood cancers brings many daily challenges.
The Leukemia & Lymphoma Society is committed to providing information, support and guidance […]
By Gloria Gamat -- 0 comments
May 3rd, 2007
These are some of the important and interesting stuff on cancer that I missed while I was enjoying the beach:
Anthocyanidins May Help Treat Leukemia
Mushrooms to Prevent Breast Cancer
Pomegranate Juice May Help Fight Lung Cancer
Risk of Head and Neck Cancer Reduced with Fruits and Veggies
Do check them out.
Now you know that I am not only in […]
By Gloria Gamat -- 1 comment
March 13th, 2007
A protein known as CDX2 is inappropriately expressed in the leukemic cell of patients with acute myeloid leukemia (AML), according to a study from Harvard Medical School appearing in the April print issue of the Journal of Clinical Investigation.
…gene encoding CDX2 is expressed in 90% of the patients with AML that they analyzed. Moreover, reducing […]
By Gloria Gamat -- 0 comments
February 16th, 2007
Acute lymphoblastic leukemia is the most common cancer in children. In such cases when the WNT pathway becomes altered, administration of medication like quercetine or Decitabine® normalizes this cell control pathway.
With this group of medicines, chemotherapy results are enhanced and survival rates improved.
Such were the findings of Spanish Scientists as described in the journal Blood […]
By Gloria Gamat -- 0 comments
Recent Comments